Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NICE yes for Xarelto to treat blood clots

July 25, 2012 Sales and Marketing Bayer, DVT, NHS, NICE, Pradaxa, VTE, Xarelto

NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in …
News

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012 Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …
News

Pfizer and Janssen’s Alzheimer’s drug fails

July 24, 2012 Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab

Pfizer and Janssen’s investigational Alzheimer’s drug bapineuzumab is no better than placebo, according to a new study. The Phase III …
News

NICE to assess high cost drugs for rare conditions

July 24, 2012 Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions

NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …
News

ABPI names new Medical, Innovation and Research director

July 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bina Rawal, Stephen Whitehead

The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade …
Appointment

EMA recommends first new gene therapy

July 24, 2012 Business Services, Research and Development, Sales and Marketing CHMP, EMA, Glybera, uniQure

Glybera is now on the cusp of becoming the first gene therapy treatment to be approved in the West. The …
News

BBSRC appoints new director of science

July 23, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BBSRC, Melanie Welham

BBSRC the government-funded bioscience research organisation has announced the appointment of Professor Melanie Welham as director of science. Welham is …
Appointment

CCGs already improving patient care

July 23, 2012 Sales and Marketing CCGs, Commissioning Board, GPs, NHS, NHSCC, reforms

Clinical Commissioning Groups – the new structures set up under the Health and Social Care Act to control most of …
News

Onyx appoints John Osborn as senior VP

July 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing John Osborn, Onyx

Onyx Pharmaceuticals has announced the appointment of John Osborn as senior vice president, Global Corporate Affairs. In his role, Osborn …
Appointment

Waggener Edstrom appoints vice president

July 20, 2012 Business Services, Medical Communications, Sales and Marketing Anna Gray, Waggener Edstrom

Comms agency Waggener Edstrom has announced that Anna Gray has been appointed to lead the agency’s UK Healthcare Practice.  Joining …
Appointment

Grünenthal and Vifor breach Code

July 20, 2012 Sales and Marketing ABPI, Grunenthal, PMCPA, Vifor, code, tapentadol

Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts …
News

Humira powers ahead as Abbott prepares split

July 19, 2012 Sales and Marketing AbbVie, Abbott, Humira, RA

Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …
News

Home Digital appoints Doctors.net.uk senior head

July 19, 2012 Business Services, Medical Communications, Sales and Marketing Doctors.net.uk, Home Digital

Digital marketing agency Home Digital has hired Marie Little as the company’s commercial director. In this newly created role she …
Appointment

Senior appointments for Takeda’s Europe and Canada team

July 18, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda Pharmaceuticals has appointed David Milton as head of Marketing & Product Portfolio Strategy, and Dr Nizamul Islam as head …
Appointment

New J&J chief still struggling with scandals

July 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Risperdal, Weldon, Xarelto, Zytiga

Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …
Feature
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026